You Position: Home > Paper
Anti-viral therapy of decompensated cirrhosis due to chronic hepatitis B
( views:299, downloads:68 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF CLINICAL INFECTIOUS DISEASES
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1674-2397.2008.04.001
- Key Word:
- No keyword available
Abstract： @@ HBV感染是严重影响全球公众健康的问题.据估计,全球约有3.5亿慢性HBV感染者,严重者可发展为肝硬化、肝衰竭或HCC.全球每年约有100万人死于HBV相关肝衰竭或HCC [1-2].肝移植是治疗终末期肝病和HCC最有效的方法,但多数乙型肝炎患者尚未发展到需要接受肝移植的阶段,或不具备进行肝移植的指征.近年来的研究证明,对慢性乙型肝炎(CHB)失代偿性肝硬化的患者积极开展抗病毒药物治疗,促使患者血清中病毒载量降低或转阴,是理想的治疗终点.当前,正确认识慢性肝病与合理用药是医务工作者面临的重要问题.
- [1]Shi-Ming Lin,I-Shyan Sheen,Rong-Nan Chien,etc.Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection[J].1999,29(3).
- [2]Perz JF,Armstrong GL,Farrington LA,etc.The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.[J].2006,45(4).
- [3]Manns MP,Boker KHW,Rosenau J,etc.Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.[J].2001,34(6).
- [4]Brown NA,Schiff ER,Rubin M,etc.Lamivudine as initial treatment for chronic hepatitis B in the United States.[J].1999,341(17).
- [5]Lawrence, Lai,Chee-Kin, Hui,Nancy, Leung,etc.Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B.[J].2006,1(3).
- [6]Mondou E,Snow A,Rousseau F,etc.Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.[J].2006,50(5).
- [7]J H, Hoofnagle,A M, Di Bisceglie,J G, Waggoner,etc.Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B.[J].1993,104(4).